Rosa Solà

Rosa Solà


Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
JLJosé López-Miranda
José López-Miranda
CMCarmen Marin
Carmen Marin
EREmilio Ros
Emilio Ros
RCR. De Caterina
R. De Caterina
Lina BadimonLina Badimon
Lina Badimon
NYN. Yiannakouris
N. Yiannakouris

11 June 2007 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
MFMontserrat Fitó
Montserrat Fitó
MGMònica Guxens
Mònica Guxens
DCDolores Corella
Dolores Corella
Guillermo T SáezGuillermo T Sáez
Guillermo T Sáez
RERamón Estruch
Ramón Estruch
FIfor the PREDIMED Study Investigators
for the PREDIMED Study Investigators
Adherence to the traditional Mediterranean diet (TMD) has been associated with a reduction in coronary heart disease (CHD), cancer, and overall mortality.1-3 This protective effect has been attributed, at least in part, to the richness of this diet in antioxidants.1,3 Current evidence indicates oxidative damage as a promoter of pathophysiological changes occurring in oxidative stress–associated diseases, such as CHD, cancer, and neurodegenerative disorders and also in aging.4 Oxidized low-density lipoprotein (oxLDL) level may play a major role in atherosclerosis and cardiovascular disease and is a commonly used marker for oxidative damage.5,6 An oxLDL predictive value for the onset of mobility disability has also been recently reported.7 Adherence to a Mediterranean type diet has been shown to be associated with lower plasma oxLDL level in a cross-sectional study8 and in a linear intervention study in healthy women.9 However, to our knowledge, no randomized controlled intervention studies have assessed the efficacy of the Mediterranean diet on in vivo LDL oxidation.

11 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MBMaria Besora-Moreno
Maria Besora-Moreno
ELElisabet Llauradó
Elisabet Llauradó
LTLucia Tarro
Lucia Tarro
RSRosa Solà
Rosa Solà
Malnutrition in the elderly could be tackled by addressing socioeconomic factors. This study aimed to determine the magnitude of the relationship between socioeconomic factors and the malnutrition or malnutrition risk (MR) in the elderly. The PubMed and SCOPUS databases were searched for observational studies that included assessment of malnutrition or/and MR and socioeconomic variables (educational level, living alone, marital status, income and occupational level, feeling of loneliness, place of residence, and food expenditure) in ≥60-year-old subjects, published in English among 2000–2018 (PROSPERO: CRD42019137097). The systematic review included 40 observational studies (34 cross-sectional and 4 cohort studies) and 16 cross-sectional studies in the meta-analysis (34,703 individuals) of malnutrition and MR in relation to low educational level (Odds Ratio (OR): 1.48; 95% Confidence Interval (CI): 1.33–1.64; p < 0.001), living alone (OR: 1.92; 95% CI: 1.73–2.14; p < 0.001), being single, widowed, or divorced (OR: 1.73; 95% CI: 1.57–1.90; p < 0.001), and low income level (OR: 2.69; 95% CI: 2.35–3.08; p < 0.001), and considering these four socioeconomic factors, malnutrition and MR is associated with them (OR: 1.83; 95% CI: 1.73–1.93; p < 0.001). Malnutrition and MR could be reduced by increasing economic level, supporting people living alone or being single, widowed, and divorced, and improving lifelong learning.

13 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJudit Companys
Judit Companys
MGMaria Jose Gosalbes
Maria Jose Gosalbes
LPLaura Pla-Pagà
Laura Pla-Pagà
LCLorena Calderón-Pérez
Lorena Calderón-Pérez
ELElisabet Llauradó
Elisabet Llauradó
RSRosa Solà
Rosa Solà
We aimed to differentiate gut microbiota composition of overweight/obese and lean subjects and to determine its association with clinical variables and dietary intake. A cross-sectional study was performed with 96 overweight/obese subjects and 32 lean subjects. Anthropometric parameters were positively associated with Collinsella aerofaciens, Dorea formicigenerans and Dorea longicatena, which had higher abundance the overweight/obese subjects. Moreover, different genera of Lachnospiraceae were negatively associated with body fat, LDL and total cholesterol. Saturated fatty acids (SFAs) were negatively associated with the genus Intestinimonas, a biomarker of the overweight/obese group, whereas SFAs were positively associated with Roseburia, a biomarker for the lean group. In conclusion, Dorea formicigenerans, Dorea longicatena and Collinsella aerofaciens could be considered obesity biomarkers, Lachnospiraceae is associated with lipid cardiovascular risk factors. SFAs exhibited opposite association profiles with butyrate-producing bacteria depending on the BMI. Thus, the relationship between diet and microbiota opens new tools for the management of obesity.

27 September 2018 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
RARosa Solà Alberich
Rosa Solà Alberich
RVRosa M Valls
Rosa M Valls
LCLorena Calderón-Pérez
Lorena Calderón-Pérez
ELElisabet Llauradó
Elisabet Llauradó
JCJudit Companys
Judit Companys
RSRosa Solà
Rosa Solà
Background The effects of probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) and those of its heat-killed form (h-k Ba8145) on human anthropometric adiposity biomarkers are unknown. Objective To assess the effect of Ba8145 and h-k Ba8145 ingestion on anthropometric adiposity biomarkers. Design Randomized, parallel, double-blind, placebo-controlled trial with abdominally obese individuals. Participants (n = 135) consumed 1 capsule/day containing 1010 colony forming unit (CFU) of Ba8145, 1010 CFU of h-k Ba8145, or placebo (maltodextrin) for 3 months. Results Ba8145 ingestion decreased waist circumference, waist circumference/height ratio, and Conicity index (P < 0.05) versus its baseline. Changes versus the placebo group reached significance (P < 0.05) after the h-k Ba8145 treatment. Ba8145 decreased the body mass index compared with baseline and placebo group (P < 0.05). The decrease in visceral fat area after Ba8145 treatments reached significance (P < 0.05) only after h-k Ba8145. When analyses by gender were performed, significance remained only for women. Diastolic blood pressure and HOMA index decreased (P < 0.05) after h-k Ba8145. Gut microbiome analyses showed an increase in Akkermansia spp. after Ba8145 treatment, particularly in the live form, which was inversely related to weight (P = 0.003). Conclusions In abdominally obese individuals, consumption of Ba8145, both as viable and mainly as heat-killed cells, improves anthropometric adiposity biomarkers, particularly in women. An increase in the gut Akkermansia genus appears as a possible mechanism involved. Our results support Ba8145 probiotic as a complementary strategy in obesity management.

1 July 2020 in Advances in Nutrition
Verified
Journal Article
Closed access
JCJudit Companys
Judit Companys
LPLaura Pla-Pagà
Laura Pla-Pagà
LCLorena Calderón-Pérez
Lorena Calderón-Pérez
ELElisabet Llauradó
Elisabet Llauradó
RSRosa Solà
Rosa Solà
RVRosa M Valls
Rosa M Valls
Fermented dairy foods (FDFs) and probiotics are promising tools for the prevention and management of cardiometabolic diseases (CMDs), respectively. The relation between the regular consumption of FDFs and CMD risk factors was assessed by prospective cohort studies (PCSs), and the effect of probiotic supplementation added into a dairy matrix on CMD parameters was evaluated by randomized controlled trials (RCTs). Moreover, the effects of probiotic supplementation added into a dairy matrix were compared with those administered in capsule/powder form. Twenty PCSs and 52 RCTs met the inclusion criteria for the systematic review and meta-analysis. In PCSs, fermented milk was associated with a 4% reduction in risk of stroke, ischemic heart disease, and cardiovascular mortality [RR (95% CI); 0.96 (0.94, 0.98)]; yogurt intake was associated with a risk reduction of 27% [RR (95% CI); 0.73 (0.70, 0.76)] for type 2 diabetes (T2D) and 20% [RR (95% CI); 0.80 (0.74, 0.87)] for metabolic syndrome development. In RCTs, probiotic supplementation added into dairy matrices produced a greater reduction in lipid biomarkers than when added into capsules/powder in hypercholesterolemic subjects, and probiotic supplementation by capsules/powder produced a greater reduction in T2D biomarkers than when added into dairy matrices in diabetic subjects. Both treatments (dairy matrix and capsules/powder) resulted in a significant reduction in anthropometric parameters in obese subjects. In summary, fermented milk consumption is associated with reduced cardiovascular risk, while yogurt intake is associated with a reduced risk of T2D and metabolic syndrome development in the general population. Furthermore, probiotic supplementation added into dairy matrices could be considered beneficial for lowering lipid concentrations and reducing anthropometric parameters. Additionally, probiotic capsule/powder supplementation could contribute to T2D management and reduce anthropometric parameters. However, these results should be interpreted with caution due to the heterogeneity of the studies and the different probiotic strains used in the studies. This trial is registered with PROSPERO (CRD42018091791) and the protocol can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018091791.